Literature DB >> 25359375

Lung disease: IL-25 blockade could reduce virus-associated asthma attacks.

Megan Cully.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25359375     DOI： 10.1038/nrd4473

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation.

Authors:  Janine Beale; Annabelle Jayaraman; David J Jackson; Sebastian L Johnston; Nathan W Bartlett; Jonathan D R Macintyre; Michael R Edwards; Ross P Walton; Jie Zhu; Yee Man Ching; Betty Shamji; Matt Edwards; John Westwick; David J Cousins; You Yi Hwang; Andrew McKenzie
Journal:  Sci Transl Med       Date:  2014-10-01       Impact factor: 17.956
  1 in total
  4 in total

1.  Airway epithelial cells enhance the immunogenicity of human myeloid dendritic cells under steady state.

Authors:  S Agrawal; R Srivastava; F Rahmatpanah; C Madiraju; L BenMohamed; A Agrawal
Journal:  Clin Exp Immunol       Date:  2017-05-22       Impact factor: 4.330

Review 2.  New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.

Authors:  Nicolás M S Gálvez; Jorge A Soto; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2017-08-11       Impact factor: 5.923

3.  IL-25 Promotes Th2 Immunity Responses in Asthmatic Mice via Nuocytes Activation.

Authors:  Chao Wang; Qingfa Liu; Fangfang Chen; Wenjuan Xu; Caiqing Zhang; Wei Xiao
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

Review 4.  Biological Properties and the Role of IL-25 in Disease Pathogenesis.

Authors:  Yuwan Liu; Zewei Shao; Guoqiang Shangguan; Qingli Bie; Bin Zhang
Journal:  J Immunol Res       Date:  2018-09-23       Impact factor: 4.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.